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Flavonoids and their precursor trans-chalcone have been reported as inhibitors of mammalian
alpha-amylase. With regard to this background, neohesperidin dihydrochalcone (NHDC) effect
was investigated toward porcine pancreatic alpha-amylase (PPA), and found to be an activator of
the enzyme. The maximal activation (up to threefold) was found to occur at 4.8 mM of NHDC, which
could be considered to have a high activation proﬁle, with regard to the alpha and beta parameters
(alpha < 1 < beta). NHDC is a non-essential activator of the enzyme and based on the results obtained
from modeling tools, it is suggested to interact with PPA at a hydrophilic site located at the N-ter-
minal, far from the active site of the enzyme.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Mammalian pancreatic a-amylases are endo-type enzymes
responsible for the hydrolysis of internal a-(1,4)-glucosidic bonds
in starch and related compounds. The hydrolysis occurs toward
the non-reducing end of the substrates [1], which are then pro-
cessed by other enzymes, ﬁnally resulting in an increase in blood
glucose in mammals [2]. Inhibition of this enzyme is thus a poten-
tial way to lower blood glucose, and may ﬁnd therapeutic applica-
tion in the diabesity state [3]. This may explain why the majority of
studies that concern effectors of this enzyme focus on its
inhibitors.
In the few reports that have been published on activators of al-
pha-amylases, anions effects have been extensively documented.
Chloride was the ﬁrst anion reported as an allosteric activator of
human pancreatic alpha-amylase (HPA) [4]; further studies re-
vealed the existence of a wide range of chloride-dependent al-
pha-amylases and the fact that the three essential residues
binding to chloride (R195, N298, and R337 in HPA) [5–8], are
highly conserved in animal alpha-amylases and some Gram-nega-
tive bacteria [9]. Other anion activators include nitrite, nitrate, and
azide [4,6].Additives including triton X-100, poly ethylene glycol (PEG) and
poly vinyl alcohol (PVA) [10], as well as xanthine compounds [11]
have also been found to activate alpha-amylase, but mostly in a
non-dose dependent manner.
The chalcone scaffold, synthesized by the help of plant chalcone
synthase, is the precursor of the natural products ﬂavonoids and
isoﬂavonoids [12]. Based on the fact that ﬂavonoids had been re-
ported as non-carbohydrate based inhibitors of mammalian al-
pha-amylase [13], we started a project on screening inhibitory
effect of compounds with similar structure to ﬂavonoids. Based
on the fact that HPA and porcine pancreatic alpha-amylase (PPA)
possess high similarity [14,15], PPA was used as a model enzyme.
This study resulted into observation of the inhibitory effect of
trans-chalcone on (PPA) [16] and prompted us to further explore
other chalcone derivatives effect on this enzyme. The present re-
port concerns the unexpected activator effect that was found for
neohesperidin dihydrochalcone (NHDC) (Scheme 1). NHDC, a syn-
thetic glycoside chalcone, is added to various foods and beverages
as a low caloric artiﬁcial sweetener; a delayed onset and a long lin-
gering menthol-licorice like sweetness have limited its use [17,18]
and it is used in industry blended with other sweeteners [19].
NHDC binding site on the human sweet taste receptor has been
identiﬁed, and overlaps with the one of cyclamate [20]. Since struc-
tural variations of sweet taste receptors may be involved in the
physiopathology of metabolic diseases (such as diabetes) [21],
and targeting the ‘‘ingestive behavior’’ of patients (via taste recep-
tors) has been proposed as a therapeutic approach [22], artiﬁcial
sweeteners may be considered as potential drugs. Furthermore,
Scheme 1. Neohesperidin dihydrochalcone (NHDC).
Scheme 2.
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oxidant [23] and anti-ulcer [24] activities have been observed.
2. Materials and methods
2.1. Material
Porcine pancreatic alpha-amylase (E.C.3.2.1.1) (DFP Treated,
Type I-A), neohesperidin dihydrochalcone, acarbose, 4-nitrophenyl
a-D-maltohexaoside, 4-nitrophenol, and 3,5-dinitrosalicylic acid
(DNS) were purchased from Sigma (St. Louis, MO, USA). Dimethyl
sulfoxide (DMSO), soluble starch, maltose and other chemicals
were obtained from Merck (Darmstadt, Germany).
2.2. Methods
2.2.1. Enzyme assay
Each compound effect was tested on PPA with the use of two
substrates, namely 4-nitrophenyl a-D-maltohexaoside (synthetic
substrate) and starch. Assays were performed in phosphate buffer,
pH 7.2 ± 0.01, at 42 C for 4-nitrophenyl a-D-maltohexaoside and
25 C for starch. Compounds were incubated with the enzyme at
25 C and stirred gently for 10 min previous to activity assay. Con-
tinuous kinetic method was used for the synthetic substrate [25]
and Bernfeld method [26] was applied when using starch. The
activity of alpha-amylase was deﬁned as produced millimoles
(mM) of p-nitrophenol and maltose as the products for the syn-
thetic and natural substrates respectively. Absorbance measure-
ments were made with the use of a Shimadzu UV-1800
spectrophotometer and activities calculated by the UV-Probe
software. PPA activity with the use of starch and 4-nitrophenyl
a-D-maltohexaoside was 560 (IU ml1) and 2580 (IU ml1), respec-
tively. Substrates concentrations were 0.8 (g 1001) for starch and
3 mM for 4-nitrophenyl-a-D-maltohexaose. Relative activity was
deﬁned as a percentage by comparison with a control sample activ-
ity, measured in the absence of the compounds. All tests were
repeated at least three times. SD and CV were calculated, and
results with CV 6 5.5 (4-nitrophenyl a-D-maltohexaoside), and
CV 6 6 (starch) considered acceptable.
2.2.2. Kinetic analysis
The kinetic model for non-essential activators (Scheme 2)
resembles the one of non-linear partial inhibitors but in opposite
direction. Km is the Michaelis–Menten constant, Ka stands for acti-
vator dissociation constant and kcat is the catalytic constant
[27–29]. a is deﬁned as the magnitude of interaction between sub-
strate and moderator binding site and b is the magnitude of
increase of catalytic constant [30]. In this study, all kinetic param-
eters were obtained with consideration to this scheme by the useof the Linweaver–Burk (L–B) plots; catalytic constants (kcat) were
calculated applying Cleland method [31,32] based on Eq. (1). Eq. (1)
refers to the following modiﬁed Michaelis–Menten equation,
v ¼ Vmax  ½S
Km  1þ
½A
Kað Þ
1þb½AaKað Þ
þ ½S  1þ
½A
aKað Þ
1þb½AaKað Þ
ð1Þ
where Vmax is the maximum velocity in absence of moderator, [S]
and [A] are substrate and activators concentrations, respectively,
and v shows the initial velocity in the absence of activator [30].
Ka, a and b values were obtained by Linweaver–Burk plotting and
replotting [28,30].
2.2.3. Docking
Docking was performed with Auto dock vina [33]. The 3L2M
pdb (www.pdb.org/) ﬁle was ﬁrst processed with the use of MOE
2010.10 (Chemical Computing Group Inc., Montreal, Canada).
Additional molecules to alpha-amylase, were deleted and the pro-
tonation state of the structure was adjusted for neutral pH. Grid
box of 60  72  64 points was used with a spacing 1.0 Å, and
the grid box center was put on x = 37.318, y = 31.139, and
z = 44.183. Gasteiger charges were assigned to protein and ligand
molecules. Exhaustiveness was set on 20 and a computer with
eight processors was utilized for the computation. Hundred poses
were generated for NHDC and preparation of the image represent-
ing the best pose was done with MOE 2010.10. An additional blind
docking was also performed with the use of the Swissdock web
server (http://swissdock.vital-it.ch/) [34].3. Results and discussion
3.1. Probing the activation effect of NHDC
Both natural (starch polymer) and synthetic substrate (4-nitro-
phenyl-a-D-maltohexaoside) were used to test the effect of 5–
1000 lM concentrations of NHDC on PPA. As shown in Fig. 1A, with
the artiﬁcial substrate, the enzyme relative activity rises by
increasing NHDC concentration, and ﬁnally reaches a maximum
of 130% in presence of 1 mM of NHDC. The activating effect of sim-
ilar amounts of NHDC is more pronounced with the use of starch as
substrate, where relative activity of the enzyme activity attains
170%, and with increasing the amount of NHDC, activity keeps on
increasing to reach a maximum of three-fold by 4.8 mM of NHDC
(Fig. 1B). The substrate nature could inﬂuence inhibitors behavior,
which may show different inhibition types in the case of PPA [35].
This effect could be attributed to the size and location of substrate
binding. More speciﬁcally, we had a similar observation relative to
the non-dose dependent xanthine activators, whose effects were
more apparent in presence of starch [11]. The (remote) possibility
that NHDC could act as a substrate was also taken into account, but
incubation of the enzyme with NHDC did not result in any signiﬁ-
cant activity (results not shown).
Fig. 1. Effect of NHDC on PPA activity in presence of artiﬁcial and natural substrates. (A) Relative activity of PPA vs. various NHDC concentrations with the use of 4-
nitrophenyl a-D-maltohexaoside as substrate. (B) Relative activity of PPA vs. various NHDC concentrations with the use of starch as substrate.
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In order to characterize this activation process in more detail,
different concentrations of NHDC (ranging from 20 to 7680 lM)
were tested against different concentrations of starch (0.025–3.2
(g 1001)). Kinetic parameters Ka, a and b were then obtained by
plotting and replotting L–B graphs (Fig. 2).Fig. 2. Kinetic analysis of experimental data. (A) Lineweaver–Burk (L–B) plot
indicating reciprocal of PPA velocity (1/V) (min mM1) vs. reciprocal of starch
concentration (1/s)(100 g1). (A-1): L–B plot; intercept of plots above (A-2), and
below the X-axis (A-3). [The ordinate shows ( control, j 20 lM NHDC, N 400 lM
NHDC,  1400 lM NHDC, 2400 lM NHDC, d 4800 lM NHDC and + 7680 lM
NHDC).] (B) Secondary L–B plot indicating 1/Y-intercept or 1/slope vs. reciprocal of
NHDC concentrations (lM). (B-1): Secondary L–B plot, (B-2): secondary L–B plot
after omitting concentrations below 1400 lM [d shows 1/Y-intercept and  shows
1/slope].In presence of inﬁnitely high concentration of activator [A] =1,
apparent Km is expressed as a. Km which is calculated by the abscis-
sa interception (1/a Km); this gives an a value of 0.94 . When
[A] =1, apparent maximum velocity equals b. Vmax[29], resulting
in a b value of 2.2. The 4800 lM concentration of NHDC was con-
sidered as the utmost activator concentration since in the next ap-
plied concentration of the ligand, the rate of catalytic reaction
decreased, possibly due to blockage of the activator binding site
[36].
Activation of an enzyme by a ligand can occur in two principal
ways. One possibility is through increase of cooperativity between
substrate and activator binding sites: binding of one increases the
afﬁnity of the other to its binding site by a magnitude of a value.
The second mode involves an increase of the turnover number by
a magnitude of b. These two parameters can deﬁne a moderator
is inhibitor or activator [30]. With a = 0.94 and b = 2.2, a < 1 < b is
indicative of a ‘‘highly activator’’ [30] proﬁle for NHDC. As the a va-
lue shows the extend of cooperativity between substrate and mod-
erator binding sites, (a < 1) shows that binding of starch increases
afﬁnity to NHDC and vice versa [30].
There are various methods for calculating Ka value , including
applying L–B secondary plots [27], drawing Dixon plot and replots
[32], and plotting (Vmax/V0  Vmax) against reciprocal of activator
concentration [37]. In the next step, attempt was made to obtain
Ka by applying L–B (Fig. 2A) and L–B replot (Fig. 2B). L–B secondary
plots are obtained by plotting 1/slope and 1/Y-intercepts of L–B
plots against 1/[activator] [28]. As it is shown in Fig. 2B-1, second-
ary plots drawn for this data series resulted in parabola curves
which made it impossible to use these plots for Ka calculation
[38]. It should be mentioned that by omitting concentrations be-
low 1400 lM from the secondary plot data series, two linear plots
could be drawn (Fig. 2B-2) whose intersection was not exactly lo-
cated on X-axis, but if this intersection point is taken into account,
then b/(a Ka), Ka would be obtained as 550 lM. In the next step,
Dixon plot was drawn (Supplementary Fig. 1). The Dixon plot
was again a parabola. With use of the other mentioned methods,
again no straight line was obtained (results not shown). However,
with known a and b values, Ka can be obtained by Eq. (1), for each
separate concentration of the activator (NHDC). These Ka values are
indicated in Table 1 for concentrations 400–4800 lM, where con-
siderable activation was observed.
EC50 (NHDC concentration in which activation is 50% of maxi-
mum activation rate) was calculated by a method previously de-
scribed by Alexander et al. [39] and obtained to be 389 lM. It is
noticeable that when velocity was plotted against NHDC concen-
tration (Supplementary Fig. 2), in all trendlines, a point of inﬂec-
tion was observed around 1400 lM. In other words, with all
concentrations of starch, around 1400 lM of NHDC, activity in-
crease seems to have a higher rate. A more detailed analysis of
Table 1
Comparison of Km and Ka for each concentration of NHDC (lM).
NHDC (lM) Km (g 1001) Ka (lM)
0 (control) 0.489 –
400 0.571 2063
1400 0.492 1132
2400 0.449 521
4800 0.465 13
Fig. 3. Investigating PPA activation in presence of acarbose and NHDC in different
concentrations of the both moderators. ( 20 lM NHDC, j 400 lM NHDC, N
2400 lM NHDC,  4800 lM NHDC, 7680 lM NHDC, d 0 NHDC (acarbose
control)). Inset table: activity in presence of the highest concentrations of NHDC
and acarbose. Though, in graph, some points seem to overlap each other, they
possess different values [R.A. (both)%: percentage of relative activity in presence of
both moderators, R.A. (acrbs)%: percentage of relative activity in presence of
acarbose].
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the lines intersection is above the X-axis while in higher concentra-
tions of NHDC (Fig. 2A-3), the intersection point is located below
the X-axis, which means that changes occur both in afﬁnity to sub-
strate (a) and catalytic constant (b) [30]. In presence of different
concentrations of NHDC, monitoring the changes in Km (Table 1)
and kcat (Table 2) shows a constant increase in kcat, while Km values
increase under 400 lM concentrations of NHDC and decrease in
higher concentrations. Overall, in presence of this activator, in-
crease of kcat seems to dominate Km changes.
Activator molecules are essential or non-essential modulators
which interact with their receptor and increase the rate of a cata-
lytic reaction [30,32]. In non-essential activation, presence of the
activator is not obligatory for the progress of the catalytic reaction
[30], and NHDC was found to be a non-essential activator.
3.3. NHDC effect in presence of PPA inhibitors acarbose or trans-
chalcone
In order to further characterize NHDC activator proﬁle, the
strong, well-known alpha-amylase inhibitor acarbose [40] was
added to the assay medium. The results have been presented in Ta-
ble 3 and Fig. 3 as enzyme relative activity in presence of both
moderators against acarbose concentrations. Enzyme activity de-
creases with increasing amount of acarbose, even in the highest
effective concentration of NHDC. On the other hand, in all concen-
trations of acarbose, including the highest amount used here
(200 lM), some activation effect are seen, achievable also by the
lowest used concentration of NHDC (20 lM) (Fig. 3, inset). These
results are suggestive of a possible competition between these
two moderators. The inhibition type of acarbose was investigated
(results not shown), and was found to be mixed-non competitive,
as reported previously [41,42]. Based on kinetic analysis interpre-Table 2
Changes in kcat (s1) alongside with increase in starch (g 1001) and NHDC concentrations
stands for control, meaning the absence of NHDC.
Starch (g 1001) kcat (cntrl) (s1) kcat (20) (s1) kcat (400) (s1) k
0.025 0.001 0.001 0.002 0
0.05 0.002 0.003 0.005 0
0.25 0.017 0.017 0.022 0
0.5 0.028 0.031 0.038 0
1.5 0.037 0.042 0.050 0
3.2 0.045 0.050 0.060 0
Table 3
PPA activity in the absence of any mediator, and in presence of NHDC or/and acarbose. [Co
NHDC c.a. (mMmin1): enzyme activity in presence of acarbose or NHDC alone; R.A. (ac/N
activity; activity both mediators (mMmin1): enzyme activity in presence of the two me
NHDC (lM) Control activity (mMmin1) Acarbose c.a. (mMmin-1) R.A. (ac)%
20 1.53 1.187 77
400 1.333 1.113 83
2400 1.694 1.238 73
4800 1.454 1.202 82tations (on PPA), the mixed inhibition mechanism of acarbose
has been related to the presence of an additional binding site for
the compound [32,43]. However, according to structural examina-
tion of the binding mode of acarbose derivatives and by applying
novel kinetic analysis on HPA, acarbose rearrangement has been
suggested to be involved in the mixed inhibitory mechanism
[44]. Based on these facts, the apparent competition between
NHDC and acarbose is not sufﬁcient to conclude for the presence
of a common binding site between the two ligands. As a comple-
mentary test, trans-chalcone was used as a competitive inhibitor
of PPA [16]. In this comparative test, concentrations were chosen
for the inhibitors which would result in a similar degree of activity
inhibition (20–30%), and would be low enough to allow NHDC ef-
fect to be clearly observed. 20 lM of trans-chalcone and 5 lM of
acarbose reduce enzyme activity to 70–80% of the control sample
activity, and the results of their effect on NHDC activation are
shown in Table 4. Pearson’s correlation coefﬁcient calculation
method [45] was applied for the results obtained for each combi-
nation of mediators. In each series of calculations, the dependence
of two variables were checked; one variable would be the PPA
activity values obtained from NHDC, acarbose, and trans-chalcone(lM). Figures indicated in parentheses correspond to NHDC concentrations, and cntrl
cat (1400) (s1) kcat (2400) (s1) kcat (4800) (s1) kcat (7680) (s1)
.003 0.003 0.003 0.004
.008 0.008 0.009 0.009
.030 0.035 0.040 0.040
.052 0.056 0.063 0.066
.065 0.073 0.081 0.093
.075 0.087 0.104 0.097
ntrol activity (mMmin1): the activity of PPA in the absence of mediators; Acarbose/
HDC)%: percentage of relative activity in presence of acarbose or NHDC to the control
diators (NHDC and acarbose).]
NHDC c.a. (mMmin1) R.A. (NHDC)% Activity both mediators (mMmin1)
1.635 107 1.008
1.601 120 1.16
3.187 188 2.421
3.019 208 2.473
Table 4
PPA activity in the absence of any mediator, and in presence of NHDC or/and trans-chalcone. [Control activity(mMmin1): the activity of PPA in the absence of mediators; NHDC/
trans-chalcone c.a. (mM min1): enzyme activity in presence of NHDC or trans-chalcone alone; R.A. (NHDC/tc)%: percentage of relative activity in presence of NHDC or trans-
chalcone to the control activity; activity both mediators (mMmin1): enzyme activity in presence of the two mediators (NHDC/trans-chalcone).]
NHDC
(lM)
Control activity
(mMmin1)
trans-Chalcone c.a.
(mMmin1)
R.A.
(tC)%
NHDC c.a.
(mMmin1)
R.A.
(NHDC)%
Activity both mediators
(mMmin1)
20 1.424 0.98 69 1.517 106 1.084
400 1.273 1.012 79 1.736 136 1.572
2400 1.5215 0.7245 68 2.945 193 2.521
4800 1.282 1.086 85 3.201 250 2.944
Table 5
The values obtained from Pearson’s correlation coefﬁcient calculations for interpret-
ing NHDC/acarbose and NHDC/trans-chalcone combination test.
Pearson’s correlation coefﬁcient for NHDC/acarbose test
NHDC 0.989
Acarbose 0.7
Pearson’s correlation coefﬁcient for NHDC / trans-chalcone test
NHDC 0.989
trans-Chalcone 0.1
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values obtained in presence of both mediators. The four series of
correlation coefﬁcients are shown in Table 5. In presence of acar-
bose, the observed activity is correlated to both NHDC and acar-
bose, when in presence of trans-chalcone, there is a very low
correlation, which may be suggestive of an absence of competition
between NHDC and trans-chalcone.
3.4. Docking experiments
In the absence of crystal structures that would indicate an exact
location for the ligand, a blind docking was performed for NHDC,
with the use of the 3L2M pdb ﬁle as receptor. Since the active site
cleft is quite extended, some poses were found to occur for the li-Fig. 4. (A) Putative binding site of NHDC (shown as spaceﬁll) on PPA (shown with ribbon
pose obtained with Autodock vina. The three aminoacids that are found to form hydrogen
site is drawn with pink color indicating hydrophilic areas and green representing hydrogand in this location. However, a second putative interacting site
was found that is located in the entrance of the central beta-barrel
of the enzyme (Domain A), and near the N-terminal of the protein
(Fig. 4A). It should be mentioned that this location was detected by
both Autodock vina and Swissdock. A binding to the active site may
probably result into inactivation of the enzyme, thus subsequent
studies were done on the second binding region. This highly hydro-
philic site has not been reported as any of the known secondary or
saccharide binding sites of the mammalian enzyme, and could only
be superposed onto a bacterial maltotriose binding site [46]. In
previous docking experiments, we had found this potential interac-
tion location for xanthine derivatives [11] and ﬂavonoids [47]. The
best pose that was obtained by Autodock is shown in Fig. 4B. In this
positioning, hydrogen bonds were found to occur between the car-
bohydrate segment of the ligand and residues R421, D402, and
R252. R252 and D402 are part of domain A the b-sheets, while
R421 belongs to a b-sheet of domain C. R 252 forms two hydrogen
bonds, with A292 (located on a b-sheet of the barrel) and Y2 (lo-
cated on N-terminal loop, in vicinity of a calcium binding residue).
D402 is a residue of a loop connecting the C-terminal a-helix of the
barrel to the b-sheets in domain C. There is also a possibility for the
aromatic moieties to form pi–H interactions in other docked posi-
tions (results not shown). The positioning of NHDC between two
domains may be indicative of a putative activation/inhibitions). (B) NHDC interactions with residues forming the putative binding site, in the best
bonds are shown as sticks (R252, D402, and R421). Molecular surface of the binding
phobic segments.
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with this site. This is an assumption based on a theoretical work,
and more detailed studies are needed in order to corroborate this
hypothesis.
4. Concluding remarks
Ligands that affect activity of enzymes, are structurally dissim-
ilar to both substrate and product, and able to bind to sites other
than the active site, have often been classiﬁed as allosteric effectors
[48]. Allosteric effect is not necessarily related to multi-subunit
proteins and small, mono-subunit polypeptide have also shown
allosteric features [4,49,50] .
Activation of alpha-amylase has been studied in detail with re-
gard to the anionic activators chloride and its substitutive anions
such as nitrite, nitrate, and azide [7]. First, chloride was reported
as an allosteric activator of alpha-amylase [4] and then observed
to bind in a pocket beneath active site cleft. Chloride is believed
to enhance positioning of the catalytic residue E233 and to stabi-
lize substrate ﬂexible binding loop [7]. The chloride binding pocket
was found to show considerable plasticity since other anions, dif-
ferent in atomic geometries, sizes, and polyatomic natures can in-
duce substantial levels of activation [7]. Interestingly, azide anion
activated the enzyme about 4- to 5-folds more than chloride but
was found to bind not to the chloride binding pocket but in an
embedded pocket near active site, thus suggesting a different
mechanism of moderation [7]. Nitrate shows different effects on
mammalian enzyme (activation rate same as chloride) [7] and
Gram-negative bacteria (no signiﬁcant activation rate) [5], so it
has been suggested that although the residues in chloride binding
site are highly conserved [9], functional roles of chloride binding
are distinctly different in the bacterial and mammalian alpha-amy-
lases [7].
Another report about alpha-amylases activators [10] introduced
polymeric structures such as triton-X-100, polyethylene glycol and
polyvinyl alcohols as activators and stabilizators of these enzymes.
It was suggested that upon binding of these compounds to the en-
zyme, an optimally folded conformation was induced. However,
the effects were not strictly dose-dependent, and may be consid-
ered not to be very speciﬁc.
Finally, some reports exist in the literature, which seem to have
been overlooked, since the main concern of researchers has been a
focus on inhibitors. In one of the earliest reports that indicated
ﬂavonoids inhibitory activity toward alpha-amylase, four out of
the twenty-one tested ﬂavonoids are activators of PPA, with gink-
getin showing ‘‘100%’’ inhibitory activity (compared to luteolin
with a 100% inhibitory activity) [41]. In a recent report that con-
cerns ﬂavonoids and glycosylated ﬂavonoids effect on human sali-
vary alpha-amylase, one of the tested structure is showing a
‘‘37%’’ inhibition [51]. The interesting fact that minor structural
differences result in either activation or inhibition of mammalian
alpha-amylase could be considered as the starting point of further
detailed studies on polyphenolic compounds.
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